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What is the nature of a conflict of 
interest in a scientific publication?
To the Editor: The use, misuse and, sometimes, failure to recognise 
conflict of interest (CoI) is a growing problem in medical publi­
cations.[1] The critique by Harcombe and Noakes[2] published in the 
December 2016 SAMJ, purporting to find many weaknesses in the 
so­called ‘Universities of Stellenbosch/Cape Town low­carbohydrate 
review’[3] is somewhat disturbing, not specifically because of the 
content of their critique, to which the authors of the systematic 
review have replied, but because of how Harcombe and Noakes have 
recruited questions of bias and implied CoI to support their views. 
Harcombe and Noakes imply bias on the part of the authors of the 
original systematic review by suggesting it is a ‘reasonable question’ 
to ask ‘what is the chance that … all the errors … disadvantaged the 
low­CHO [carbohydrate]’ diet … when many of the authors … are on 
public record as being vigorously opposed to lower­ or low­CHO diets 
and those who promote such eating plans.’ Indeed, their ‘Opinion’ 
title goes further by suggesting there might have been ‘mischief.’ Does 
going on public record opposing or promoting a scientific position 
mean anything with regard to the likely validity of the findings of a 
subsequent peer­reviewed paper? If so, the same arguments could be 
made about Harcombe and Noakes, who have been far more public 
in their advocacy for a particular interpretation of the low­CHO diet 
question. Should we read any bias into their analysis simply because 
they have invested so much time and effort in claiming benefits for 
a low­CHO diet? Clearly, Harcombe and Noakes would argue that it 
would be rather unscientific to take such a position. 
The claim that scientists who have held a particular position in a 
public debate are likely to be biased in any future engagement on that 
issue is one of a number of strategies used by corporations to discredit 
scientists whose research has found that corporate products or 
activities are health­harming.[4] These industry arguments posit that 
because a particular scientist has previously held a public position on 
a scientific finding of public health importance, they have a CoI no 
different to that of a scientist employed by an industry with financial 
interests in the outcome of a research investigation into their product 
or activity. I have personally experienced such arguments in engaging 
with industry­employed scientists in the field of pesticide hazards.[5] 
Using this argument, industry interests seek to neutralise science that 
produces findings critical of its operations by widening the scope of 
CoI so unreasonably as to include simply holding a public opinion. 
In that construction, because everyone has an opinion, everyone 
must have a CoI, so CoI becomes irrelevant for assessing the validity 
of a study. 
Yet the CoI declared by Harcombe and Noakes appears quite 
limited. Listed are a number of statements pertaining to financial 
interests (or non­interests of the authors). But strangely, nowhere 
in the declaration is it mentioned that Prof. Noakes is facing a 
disciplinary hearing by the Health Professions Council of South 
Africa in which the validity of his claims regarding the low­CHO 
diet is relevant to the question of his professional behaviour. No 
matter what one believes about whether the charges are groundless 
or justified, it is undeniable that a systematic review that produces 
evidence that contradicts his public claims is obviously highly 
damaging to his case, and a published critique of the systematic 
review would be of direct help to defend himself at the hearing. Yet 
this interest is not mentioned at all in the declaration.
CoI in the context of publication needs to be understood not as 
a matter of holding strong opinions, but as a situation in which an 
individual’s interests diverge from their scientific responsibilities 
such that they may be seen to achieve unusual personal advantage 
from the publication of the article.[6] The World Health Organization 
defines CoI as occurring when the ‘ability to exercise judgement in 
one role is impaired by his or her obligations in another role or by 
the existence of competing interests,’ which could ‘create a risk of a 
tendency towards bias in favour of one interest over another or that 
the individual would not fulfil his duties impartially’.[7] This could 
take the form of a financial or material advantage, as most commonly 
framed by CoI statements, but also includes non­financial interest – 
including the arena of litigatory or regulatory advantages. Just as 
corporations try to generate pseudoscience that they can advance in 
defending themselves from claims in court, individuals who might 
benefit in a litigatory context from a particular publication are also in 
a position of CoI. Readers need to know that when they interpret a 
particular set of findings emerging from a publication. 
CoI statements should not be used to discount results of a 
particular paper, but to give readers the opportunity to understand 
how CoI may have been present in the interpretation and to ‘judge 
the paper in a more informative way’.[8] 
Managing CoI in publications is not easy, and deciding what 
constitutes a non­financial CoI is not always obvious. For example, 
different sources cite academic commitments, personal relationships 
or favours, political or religious beliefs, relationships to the journal 
editor or institutional affiliations as non­financial conflicts of 
interest. [6,7,9,10] The International Committee of Medical Journal 
Editors’ form for disclosure of potential CoIs lists a very broadly 
inclusive frame of ‘other relationships or activities that readers could 
perceive to have influenced, or that give the appearance of potentially 
influencing, what you wrote in the submitted work’.[11] However, a 
recent survey of 117 ‘core’ clinical journals noted that non­financial 
CoI criteria used by journals were most commonly issues related 
to ‘personal relationship’, ‘professional relationships’ and ‘academic 
associations’, and that ‘personal opinion’ and author ship of original 
studies or editorials on the same subject were regarded as constituting 
CoI in only three journals (less than 5% of all responding journals).[12]
This signals the difficulties in managing CoI in health scientific 
publications. But unless we make a start by reflecting carefully 
on what it is, what it is not and how it should be handled, we risk 
allowing the notion to be recruited for partisan reasons in contentious 
debates, and subordinating science to vested interests. With major 
public health policies looming in South Africa, such as legislation 
on alcohol advertising, the National Health Insurance, regulation of 
e­cigarettes and the adoption of sugar­sweetened beverage taxes, we 
can anticipate intense lobbying by vested interests to shape public 
opinion as to what really is the best evidence. We desperately need 
clear CoI provisions unambiguously executed to ensure that vested 
interests are not allowed to use our journals to benefit some interests 
at the expense of science.
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